Detalles de la búsqueda
1.
Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab.
Blood
; 140(8): 839-850, 2022 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35605176
2.
ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Future Oncol
; 16(10): 517-523, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32207333
3.
Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial.
Eur J Haematol
; 98(3): 254-262, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27862308
4.
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.
Blood
; 124(1): 49-62, 2014 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-24797299
5.
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis.
Blood
; 117(6): 1817-21, 2011 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21139079
6.
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia.
Blood
; 114(16): 3382-91, 2009 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19605849
7.
Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission: long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG).
Br J Haematol
; 144(1): 95-8, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19016732
8.
CLL2-BIG: sequential treatment with bendamustine, ibrutinib and obinutuzumab (GA101) in chronic lymphocytic leukemia.
Leukemia
; 33(5): 1161-1172, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30568174
9.
Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia.
Hemasphere
; 6(4): e692, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35284802
10.
Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial.
Leukemia
; 36(8): 2125-2128, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35752657
11.
Chemotherapy combination treatment regimens with fludarabine in chronic lymphocytic leukemia.
Hematol J
; 5 Suppl 1: S20-30, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15079150
12.
Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial.
J Clin Oncol
; 30(9): 980-8, 2012 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22331940
13.
Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.
J Clin Oncol
; 30(26): 3209-16, 2012 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22869884
14.
Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.
J Clin Oncol
; 29(26): 3559-66, 2011 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21844497
15.
Use of alemtuzumab and rituximab consolidation in CLL: Pros and cons.
Curr Hematol Malig Rep
; 4(1): 43-6, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20425437
16.
Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.
Br J Haematol
; 136(1): 63-72, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17083342
17.
Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group.
J Clin Oncol
; 25(13): 1722-31, 2007 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17389338
18.
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia.
Blood
; 107(3): 885-91, 2006 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16219797
Resultados
1 -
18
de 18
1
Próxima >
>>